Serotonin Has a Key Role in Pathogenesis of Experimental Colitis

Slides:



Advertisements
Similar presentations
Volume 131, Issue 4, Pages (October 2006)
Advertisements

Volume 133, Issue 5, Pages (November 2007)
Volume 138, Issue 3, Pages e2 (March 2010)
Volume 78, Issue 11, Pages (December 2010)
Volume 136, Issue 1, Pages (January 2009)
Volume 135, Issue 2, Pages e3 (August 2008)
Volume 132, Issue 4, Pages (April 2007)
Volume 124, Issue 5, Pages (May 2003)
Volume 136, Issue 3, Pages (March 2009)
Volume 138, Issue 3, Pages e4 (March 2010)
Volume 138, Issue 7, Pages (June 2010)
Volume 136, Issue 7, Pages e4 (June 2009)
Volume 130, Issue 2, Pages (February 2006)
Volume 131, Issue 4, Pages (October 2006)
Volume 128, Issue 5, Pages (May 2005)
Volume 143, Issue 5, Pages e4 (November 2012)
Therapeutic potential of follistatin for colonic inflammation in mice
Volume 137, Issue 6, Pages e2 (December 2009)
Volume 17, Issue 6, Pages (December 2002)
Volume 127, Issue 2, Pages (August 2004)
Volume 128, Issue 4, Pages (April 2005)
Volume 137, Issue 5, Pages e1 (November 2009)
Volume 141, Issue 5, Pages (November 2011)
Volume 142, Issue 2, Pages e2 (February 2012)
Galectin-1 suppresses experimental colitis in mice
Volume 134, Issue 1, Pages e1 (January 2008)
Volume 145, Issue 3, Pages e3 (September 2013)
Volume 132, Issue 7, Pages (June 2007)
Volume 124, Issue 3, Pages (March 2003)
PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
Volume 127, Issue 3, Pages (September 2004)
Volume 140, Issue 7, Pages (June 2011)
Volume 25, Issue 11, Pages (November 2017)
Volume 136, Issue 2, Pages (February 2009)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 139, Issue 6, Pages (December 2010)
A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice  Tohru Funakoshi, Kenichiro Yamashita, Nobuki.
Volume 140, Issue 2, Pages e4 (February 2011)
Volume 132, Issue 5, Pages (May 2007)
Volume 143, Issue 1, Pages (July 2012)
T Cell-Derived Lymphotoxin Regulates Liver Regeneration
Volume 138, Issue 2, Pages (February 2010)
Volume 130, Issue 6, Pages (May 2006)
Volume 138, Issue 4, Pages (April 2010)
This Month in Gastroenterology
Volume 134, Issue 7, Pages e3 (June 2008)
Volume 129, Issue 3, Pages (September 2005)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Qinglan Zhao, Yi Wei, Stephen J. Pandol, Lingyin Li, Aida Habtezion 
Molecular Therapy - Nucleic Acids
The PepT1–NOD2 Signaling Pathway Aggravates Induced Colitis in Mice
Volume 119, Issue 4, Pages (October 2000)
Volume 135, Issue 5, Pages e5 (November 2008)
A2B Adenosine Receptor Gene Deletion Attenuates Murine Colitis
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 142, Issue 5, Pages (May 2012)
Leptin: A pivotal mediator of intestinal inflammation in mice
Helminth Infection Enhances Disease in a Murine TH2 Model of Colitis
CD8+ Cytotoxic T Cells Induce Relapsing Colitis in Normal Mice
Volume 141, Issue 5, Pages (November 2011)
Volume 132, Issue 2, Pages (February 2007)
Colonic bacterial superantigens evoke an inflammatory response and exaggerate disease in mice recovering from colitis  Jun Lu, Arthur Wang, Sara Ansari,
Volume 140, Issue 4, Pages (April 2011)
Volume 125, Issue 3, Pages (September 2003)
Volume 136, Issue 7, Pages (June 2009)
Volume 137, Issue 6, Pages e2 (December 2009)
Volume 128, Issue 3, Pages (March 2005)
Volume 24, Issue 1, Pages (January 2006)
Presentation transcript:

Serotonin Has a Key Role in Pathogenesis of Experimental Colitis Jean–Eric Ghia, Nan Li, Huaqing Wang, Matthew Collins, Yikang Deng, Rami T. El–Sharkawy, Francine Côté, Jacques Mallet, Waliul I. Khan  Gastroenterology  Volume 137, Issue 5, Pages 1649-1660 (November 2009) DOI: 10.1053/j.gastro.2009.08.041 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Effects of lack of 5-HT in the gut in the development of DSS-induced colitis. TPH1+/+ and TPH1−/− mice were given 5% DSS solution in the drinking water to induce colitis. Control mice received water without DSS. (A) DAI. (B) Macroscopic damage score in DSS-induced colitis on day 5 after DSS-induced colitis and in mice without colitis. (C) Histologic scores on day 5 after administration of DSS. (D) (a) Light micrograph of an H&E-stained colonic section from a TPH1+/+ mouse on day 5 after administration of DSS. (b) Light micrograph of an H&E-stained colonic section from a TPH1−/− mouse on day 5 after administration of DSS. Original magnification 10×. Each value represents the mean ± SEM from 12 mice. *Significantly lower (P < .05) in DSS-treated TPH1−/− mice compared with DSS-treated TPH1+/+ mice. Gastroenterology 2009 137, 1649-1660DOI: (10.1053/j.gastro.2009.08.041) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Effects of the lack of 5-HT on MPO activity, CRP, and proinflammatory cytokines (TNF-α, IL-1β, and IL-6) in DSS-induced colitis. TPH1+/+ and TPH1−/− mice were given 5% DSS solution in the drinking water to induce colitis and killed on day 5 after administration of DSS. (A) MPO activity, (B) serum CRP levels, (C) TNF-α levels in colonic tissues, (D) IL-1β levels in colonic tissues, and (E) IL-6 levels in colonic tissues. Each value represents the mean ± SEM from 12 mice. *Significantly lower (P < .05) in DSS-treated TPH1−/− mice compared with DSS-treated TPH1+/+ mice. Gastroenterology 2009 137, 1649-1660DOI: (10.1053/j.gastro.2009.08.041) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 Effects of inhibition of 5-HT synthesis by a pharmacologic agent in DSS-induced colitis. Wild-type (TPH1+/+) mice were given 5% DSS solution in the drinking water to induce colitis in parallel to continued PCPA (300 mg/kg per day) or vehicle (saline) treatment. (A) DAI in PCPA- and vehicle (saline)-treated mice. (B) Macroscopic scores in mice on day 5 after administration of DSS. (C) Histologic scores in mice on day 5 after administration of DSS. (D) (a) Light micrograph of an H&E-stained colonic section from a vehicle-treated mouse on day 5 after administration of DSS. (b) Light micrograph of an H&E-stained colonic section from a PCPA-treated mouse on day 5 after administration of DSS. Original magnification 10×. Each value represents the mean ± SEM from 12 mice. *Significantly lower (P < .05) in PCPA-treated mice as compared with vehicle-treated mice. Gastroenterology 2009 137, 1649-1660DOI: (10.1053/j.gastro.2009.08.041) Copyright © 2009 AGA Institute Terms and Conditions

Figure 4 Effects of 5-HTP treatment in DSS-induced colitis. TPH1+/+ and TPH1−/− mice were given 5% DSS solution in the drinking water to induce colitis in parallel to continued 5-HTP (50 mg/kg twice a day) or vehicle (saline) treatment. (A) 5-HT–expressing EC cells on day 5 after administration of DSS. (B) DAI in 5-HTP– and vehicle (saline)-treated mice. (C) Macroscopic scores on day 5 after administration of DSS. (D) Histologic scores on day 5 after administration of DSS. (E) (a) Light micrograph of an H&E-stained colonic section from a 5-HTP–treated TPH1+/+ mouse on day 5 after administration of DSS and (b) from a 5-HTP–treated TPH1−/− mouse on day 5 after administration of DSS. Original magnification 10×. Each value represents the mean ± SEM from 10 mice. *Significantly higher in 5-HTP–treated mice compared with vehicle-treated mice. Gastroenterology 2009 137, 1649-1660DOI: (10.1053/j.gastro.2009.08.041) Copyright © 2009 AGA Institute Terms and Conditions

Figure 5 Macrophage staining and accumulation of F4/80+ cells in DSS-induced colitis in TPH1+/+ and TPH1−/− mice. Colitis was induced by DSS (5%), and F4/80+ cells were evaluated on day 5 after the induction of colitis. (A) F4/80+ area. Data are expressed as the percentages of the positive staining areas of the total area. Each bar represents the mean ± SEM. *Significantly lower (P < .05) in TPH1−/− mice compared with TPH1+/+ mice after administration of DSS. (B) (a) F4/80 immunostaining of colon tissue of TPH1+/+ mice on day 5 after administration of DSS. (b) F4/80 immunostaining of colon tissue of TPH1−/− mice on day 5 after administration of DSS. (C) Effect of 5-HT stimulation on IL-1β and IL-6 production from macrophages in vitro. Peritoneal macrophages (3 × 105 cells/mL) were harvested from wild-type (TPH1+/+) mice and cultured with medium or with 5-HT (10–10 mol/L) with or without the presence of LPS (100 ng/mL) and with or without the presence of NF-κB inhibitor (10 μmol/L). The levels of IL-1β present in the culture supernatant were investigated by enzyme-linked immunosorbent assay. *Significantly higher compared with medium-treated cells and #significantly different between the groups tested. Gastroenterology 2009 137, 1649-1660DOI: (10.1053/j.gastro.2009.08.041) Copyright © 2009 AGA Institute Terms and Conditions

Figure 6 Macroscopic and histologic damage in DNBS-induced colitis in TPH1+/+ and TPH1−/− mice. Colitis was induced by intracolonic administration of DNBS (5 mg), and macroscopic damage was evaluated on day 3 after administration of DNBS. The control mice were killed 3 days after intracolonic administration of 50% ethanol. (A) Macroscopic damage scores. (B) Histologic damage scores. (C) (a) Light micrograph of an H&E-stained colonic section from a TPH1+/+ mouse on day 3 after administration of DNBS. (b) Light micrograph of an H&E-stained colonic section from a TPH1−/− mouse on day 3 after administration of DNBS. (D and E) Effects of the lack of 5-HT on MPO activity and IL-1β production in DNBS-induced colitis in TPH1+/+ and TPH1−/− mice. Each value represents the mean ± SEM for 8 mice. *Significantly lower in DNBS-treated TPH1−/− mice than DNBS-treated TPH1+/+ mice. Gastroenterology 2009 137, 1649-1660DOI: (10.1053/j.gastro.2009.08.041) Copyright © 2009 AGA Institute Terms and Conditions